| MIRA PHARMACEUTICALS INC. |
| USA |
| Gesundheit |
| US60458C1045 / A3EQWL |
| K6S (Frankfurt) / MIRA (NASDAQ) |
| FRA:K6S, ETR:K6S, K6S:GR, NASDAQ:MIRA |
| - |
| https://www.mirapharmaceu.. |
|
Mira Pharmaceuticals Inc. operates in the biotechn..
>Volltext.. |
| 44.17 Mio. EUR |
| 37.68 Mio. EUR |
| - |
| -6 Mio. EUR |
| -23.98 Mio. EUR |
| -1.28 EUR |
| - |
| 2.23 Mio. EUR |
| -4.5 Mio. EUR |
| 89.79 |
| - |
| -139.87% |
| - |
| - |
| - |
| - |
| MIRA PHARMACEUTICALS, MIRA PHARMACEUTICAL, MIRA PHARMA |
| 03.02.26 |
|